Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
11 | 65569348 | non coding transcript exon variant | C/T | snv | 5.7E-02 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||||
|
11 | 65569348 | non coding transcript exon variant | C/T | snv | 5.7E-02 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||||
|
0.807 | 0.240 | 11 | 65571690 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||||
|
0.807 | 0.240 | 11 | 65571690 | missense variant | G/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
0.807 | 0.240 | 11 | 65571690 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.240 | 11 | 65571690 | missense variant | G/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.807 | 0.240 | 11 | 65571690 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.807 | 0.240 | 11 | 65571690 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.240 | 11 | 65571690 | missense variant | G/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
0.807 | 0.240 | 11 | 65571690 | missense variant | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.807 | 0.240 | 11 | 65571690 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.851 | 0.160 | 11 | 65570699 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||||
|
0.851 | 0.160 | 11 | 65570699 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Eye Diseases | 0.010 | 1.000 | 1 | 2003 | 2003 | |||||||
|
0.851 | 0.160 | 11 | 65570699 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2003 | 2003 | |||||||
|
0.851 | 0.160 | 11 | 65570699 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2003 | 2003 | |||||||
|
0.851 | 0.160 | 11 | 65570699 | missense variant | G/A | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.120 | 11 | 65571531 | missense variant | A/C | snv | 4.0E-06 |
|
Neoplasms; Nervous System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 11 | 65570617 | missense variant | C/A;T | snv | 2.8E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 11 | 65570617 | missense variant | C/A;T | snv | 2.8E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 11 | 65570617 | missense variant | C/A;T | snv | 2.8E-05 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.160 | 11 | 65570895 | missense variant | C/T | snv | 4.8E-05 | 1.4E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.925 | 0.160 | 11 | 65570895 | missense variant | C/T | snv | 4.8E-05 | 1.4E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
1.000 | 0.080 | 11 | 65571523 | missense variant | C/G | snv | 4.0E-06 |
|
Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 |